|
|
||||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Clinical Department of Radiological and Histocytopathological Sciences, University of Bologna, 40138 Bologna, Italy
2 Neuroscience Department, University of Padova, and Venetian Institute of Molecular Medicine, 35128 Padova, Italy
Correspondence to:
Professor C Angelini
Department of Neurosciences, University of Padova, via Giustiniani 5, 35128 Padova, Italy; corrado.angelini{at}unipd.it
Background: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process. Dysferlin is known to play an essential role in skeletal muscle fibre repair, but the process underlying the pathogenetic mechanism of dysferlinopathy is not completely understood.
Aims: To define both specific alterations of muscle fibres and a possible sequential mechanism of myopathy development.
Methods: A histological, immunohistochemical, and ultrastructural analysis of 10 muscle biopsies from patients with molecularly diagnosed dysferlinopathy.
Results: An inflammatory response was seen in most of the muscle biopsies. The immunohistochemical pattern demonstrated active regeneration and inflammation. Non-necrotic fibres showed alterations at different submicroscopic levels, namely: the sarcolemma and basal lamina, subsarcolemmal region, and sarcoplasmic compartment. In the subsarcolemmal region there were prominent aggregations of small vesicles, probably derived from the Golgi apparatus, which consisted of empty, swollen cisternae. In the sarcolemma there were many gaps and microvilli-like projections, whereas the basal lamina was multilayered.
Conclusions: The histopathological, immunohistochemical, and ultrastructural data show that dysferlinopathy is characterised by a very active inflammatory/degenerative process, possibly associated with an inefficient repair and regenerative system. The presence of many crowded vesicles just beneath the sarcolemma provides submicroscopical proof of a defective resealing mechanism, which fails to repair the sarcolemma.
Abbreviations: LGMD, limb girdle muscular dystrophy; MHC, major histocompatibility class; MM, Miyoshi myopathy
This article has been cited by other articles:
![]() |
M. Spinazzi, S. Cazzola, M. Bortolozzi, A. Baracca, E. Loro, A. Casarin, G. Solaini, G. Sgarbi, G. Casalena, G. Cenacchi, et al. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function Hum. Mol. Genet., November 1, 2008; 17(21): 3291 - 3302. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagaraju, R. Rawat, E. Veszelovszky, R. Thapliyal, A. Kesari, S. Sparks, N. Raben, P. Plotz, and E. P. Hoffman Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B Am. J. Pathol., March 1, 2008; 172(3): 774 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Bernatchez, L. Acevedo, C. Fernandez-Hernando, T. Murata, C. Chalouni, J. Kim, H. Erdjument-Bromage, V. Shah, J.-P. Gratton, E. M. McNally, et al. Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function J. Biol. Chem., October 19, 2007; 282(42): 30745 - 30753. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nguyen, G. Bassez, M. Krahn, R. Bernard, P. Laforet, V. Labelle, J. A. Urtizberea, D. Figarella-Branger, N. Romero, S. Attarian, et al. Phenotypic Study in 40 Patients With Dysferlin Gene Mutations: High Frequency of Atypical Phenotypes Arch Neurol, August 1, 2007; 64(8): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tidball and M. Wehling-Henricks Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo J. Physiol., January 1, 2007; 578(1): 327 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Washington and S. Ward FER-1 regulates Ca2+-mediated membrane fusion during C. elegans spermatogenesis J. Cell Sci., June 15, 2006; 119(12): 2552 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Doherty, A. Cave, D. B. Davis, A. J. Delmonte, A. Posey, J. U. Earley, M. Hadhazy, and E. M. McNally Normal myoblast fusion requires myoferlin Development, December 15, 2005; 132(24): 5565 - 5575. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |